TSC22D3 and autoimmune disease: GILZ is involved in the modulation of the same signaling immune responses and inflammation-related pathways implicated in GC-induced anti-inflammatory and immunosuppressive activities (Figure 1), suggesting that targeting GILZ can constitute a new approach to the treatment of inflammatory/autoimmune diseases.